Had COVID before and think you’re immune? Think again: Not all infections are created equal, with antibody responses varying wildly, experts say. Read more Retirees who cruise the internet stay sharp: Those who logged on more often posted substantially higher scores on thinking tests. Why is the million-dollar question. ReadContinue Reading

CDC approves booster shots for millions of Americans: In a rare move, CDC Director Dr. Rochelle Walensky said those who have jobs that make them vulnerable to COVID exposure can also get the extra doses. Read more COVID vaccines well worth it for cancer patients: A pair of clinical trialsContinue Reading

Here are some of HealthDay’s top stories for Wednesday, Sept. 22: Pregnant women, do your baby a favor and get a COVID vaccine: A new study found that mothers-to-be who had either the Pfizer or Moderna shots passed high levels of antibodies to their infants. Read more CDC advisory panelContinue Reading

Here are some of HealthDay’s top stories for Tuesday, Sept. 21: Pandemic has changed what and how families eat: A new poll shows half are cooking at home more often and two-thirds are making healthier food choices. But 20% of parents, many of whom said they felt stressed, are pickingContinue Reading

MONDAY, Sept. 20, 2021 (HealthDay News) — Millions of U.S. sleep apnea patients are scrambling to find ways to protect their nightly slumber, following a voluntary recall from one of the nation’s leading manufacturers of CPAP breathing machines. Philips Respironics agreed to a voluntary recall of continuous positive airway pressureContinue Reading

Here are some of HealthDay’s top stories for Monday, Sept. 20: Lower dose of Pfizer vaccine works in kids as young as 5: The pharmaceutical giant announced Monday that a dose that is one-third the strength of adult doses triggered a robust immune response in young children. Read more GoodContinue Reading

FRIDAY, Sept. 17, 2021 (HealthDay News) — Pfizer is expanding the recall of its anti-smoking drug Chantix (varenicline), the company announced Friday. The nationwide recall of all Chantix 0.5 mg and 1 mg tablets was prompted because they may contain levels of a nitrosamine, N-nitroso-varenicline, that are at or aboveContinue Reading

Here are some of HealthDay’s top stories for Friday, Sept. 17: FDA advisory panel meets on need for COVID-19 booster shots. Presented with evidence seemingly pro and con, an advisory committee to the U.S. Food and Drug Administration will convene Friday to decide whether or not Pfizer-BioNTech vaccine booster shotsContinue Reading